Frazier Healthcare Partners Adds Priti Shah to its Center of Excellence

Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, is pleased to announce the addition of Priti Shah as Partner, Product Excellence within its Center of Excellence (CoE). The appointment expands Frazier's Center of Excellence with dedicated product strategy expertise and execution capability that will help portfolio companies strengthen product strategy, accelerate platform development, and drive product-led revenue growth.

Frazier continues to deepen its Center of Excellence, which delivers Fortune 500 talent to its portfolio companies across key areas, including Human Capital, Technology & Innovation, Data Analytics & AI, M&A & Corporate Development, Finance, Operations, Legal, Commercial Excellence, ESG, and now Product Excellence.

"Product Excellence is a natural addition to the Center of Excellence as our portfolio companies increasingly compete on the strength of their product innovation, development, and marketing capabilities," said Andy Caine, CoE COO & Partner. "Priti has led multi-product platform expansions, cloud migrations, and AI integration at scale across healthcare technology companies. That experience will be an invaluable resource as our management teams navigate those same transformations."

Ms. Shah is a healthcare technology executive with over 20 years of experience spanning product, technology, and commercial leadership. Most recently, she served as Chief Product & Technology Officer of Iodine Software, a provider of AI-powered clinical intelligence solutions, where she owned the full product platform, including engineering, data science, design, infrastructure, and strategic marketing. Under her leadership, Iodine evolved from a single-product company into a multi-product AI-powered clinical intelligence platform serving many of the nation’s premier health systems. She also led the company’s migration to public cloud infrastructure and strengthened its senior leadership team.

Previously, Ms. Shah served as Chief Product Officer at Finvi, where she shaped product vision and corporate strategy and led the transformation of the company’s existing product suite to a SaaS model. Before Finvi, she was Vice President, Global Product & Solutions at Wolters Kluwer Health, where she led a global clinical effectiveness SaaS portfolio and built an international commercial business unit. Earlier in her career, Ms. Shah held product and corporate development roles at Skillsoft and Citrix Systems.

Ms. Shah holds an MBA from Rochester Institute of Technology and completed the General Management Program at Harvard Business School. She earned her undergraduate degrees from the University of Mumbai.

“Every healthcare company I’ve worked with faces a version of the same challenge: how to evolve from a point solution into a platform that compounds value,” said Ms. Shah. “Frazier’s portfolio sits at the center of that transition, spanning provider technology, clinical intelligence, and healthcare services. I’m excited to work alongside these management teams at the moments when product and strategic decisions can have the greatest impact on long-term enterprise value.”

According to Towards Healthcare, the healthcare private equity market is projected to grow significantly, with estimates indicating the market size will increase from USD 911.84 million in 2026 to approximately USD 2370.62 million by 2035, expanding at a CAGR of 11.2% from 2026 to 2035. Private equity can provide capital and strategic guidance to healthcare entities, fostering innovation and growth. It can also improve operational and technological efficiencies. For instance, a small hospital might gain greater purchasing leverage by being part of a larger group of hospitals owned by a private equity firm. 

Private equity refers to not publicly traded, investor-based ownership of healthcare service providers. Private equity investments include hospitals, long-term care facilities, hospice agencies, outpatient clinics, physician practices, urgent care facilities, and ambulatory surgery centers. Private equity can benefit an organization, but it can also lead to problems such as increased costs for patients, staffing reductions, and a reduction in the quality of care. healthcare private equity firms operate in specific verticals with stable-ish cash flows, such as healthcare services, nursing facilities, medical devices, equipment, and healthcare IT.

About Frazier Healthcare Partners

Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $11 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over the past 35 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier is headquartered in Seattle, Washington, with an office in New York City, and invests broadly across the U.S., Canada, and Europe.

A recent report by Towards Healthcare highlights that the Healthcare Private Equity Market is growing, as Private equity’s role in health care is rapidly growing, particularly through acquisitions of high-margin specialist practices.  Private equity firms supply large funds to upgrade medical equipment, expand physical infrastructure, and build new facilities. PE firms can often bring more resources, like human resources, compliance, and collections and billing support, as well as funds for EMR systems, at-risk payor contracting, and investment in ancillaries, like surgery centers. PE investments can greatly benefit Indian healthcare, but the focus must remain on patient-centric care.